Ignite Creation Date:
2025-12-26 @ 11:13 AM
Ignite Modification Date:
2026-04-22 @ 2:35 PM
Study NCT ID:
NCT03070028
Status:
COMPLETED
Last Update Posted:
2020-05-13
First Post:
2017-02-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Minimally Invasive Treatment Methods for Pilonidal Disease
Sponsor:
Uşak University
Organization:
Study Overview
Official Title:
Randomized Prospective Comparison of Crystallized Phenol and Platelet Rich Plasma Applications in Treatment of Pilonidal Sinus Disease
Status:
COMPLETED
Status Verified Date:
2020-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients with pilonidal sinus disease will be randomised to two groups (crystallised phenol and platelet rich plasma). Sinus healing time, patient satisfaction, complications and recurrence rates will be compared.
Detailed Description:
Patients with pilonidal sinus disease will be treated by either crystallised phenol or platelet rich plasma application. Treatment results, healing time, postprocedural complications, patient satisfaction and recurrences will be compared.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: